They used genetic variants in the HMGCR gene as proxies for HMGCR inhibition by statins, and both studies confirmed a causal association between statin treatment and an increased risk of type 2 diabetes (T2D) [8,9]. Here, HMGCR is linked to type 2 diabetes mellitus.